Related Experiment Video
Updated: Apr 20, 2026
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
The melanoma revolution: from UV carcinogenesis to a new era in therapeutics
Jennifer A Lo1, David E Fisher2
1Cutaneous Biology Research Center, Department of Dermatology and MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Abstract:
Melanoma, the deadliest form of skin cancer, is an aggressive disease that is rising in incidence. Although melanoma is a historically treatment-resistant malignancy, in recent years unprecedented breakthroughs in targeted therapies and immunotherapies have revolutionized the standard of care for patients with advanced disease. Here, we provide an overview of recent developments in our understanding of melanoma risk factors, genomics, and molecular pathogenesis and how these insights have driven advances in melanoma treatment. In addition, we review benefits and limitations of current therapies and look ahead to continued progress in melanoma prevention and therapy. Remarkable achievements in the field have already produced a paradigm shift in melanoma treatment: Metastatic melanoma, once considered incurable, can now be treated with potentially curative rather than palliative intent.
Insights
Recent breakthroughs in targeted therapies and immunotherapies have revolutionized melanoma treatment. Advanced melanoma, once incurable, can now be treated with curative intent, offering new hope for patients.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Melanoma is an aggressive skin cancer with rising incidence.
- Historically, melanoma has been treatment-resistant.
- Recent advances have transformed care for advanced melanoma.
Purpose of the Study:
- To provide an overview of recent developments in melanoma.
- To discuss how insights into risk factors, genomics, and pathogenesis drive treatment advances.
- To review current therapy benefits, limitations, and future directions.
Main Methods:
- Review of recent literature on melanoma risk factors, genomics, and molecular pathogenesis.
- Analysis of current targeted therapies and immunotherapies for advanced melanoma.
- Exploration of future directions in melanoma prevention and treatment.
Main Results:
- Unprecedented breakthroughs in targeted therapies and immunotherapies have revolutionized melanoma care.
- Understanding of melanoma risk factors, genomics, and pathogenesis has driven treatment advances.
- Metastatic melanoma, previously incurable, can now be treated with potentially curative intent.
Conclusions:
- Current therapies have produced a paradigm shift in melanoma treatment.
- Advanced melanoma care has moved from palliative to potentially curative intent.
- Continued progress in melanoma prevention and therapy is anticipated.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:19Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...